Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: oral vinorelbine|DRUG: Capecitabine|DRUG: Gemcitabine 1250 mg/m²|DRUG: Gemcitabine 1000 mg/m²|DRUG: Paclitaxel|DRUG: Docetaxel
Sponsor: Pierre Fabre Medicament